Need help finding what you are looking for?
Contact Us
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2057473
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2057473
Companion Animal Diagnostic Market by Product (Consumable, Instrument), Technology (Immunodiagnostic, ELISA, PCR Test, Urinalysis, Hematology), Animal Type (Dog, Cat), Application (Clinical Pathology, Virology), End User - Global Forecast to 2031
PUBLISHED:
PAGES: 575 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The companion animal diagnostics market is expected to grow from USD 3.56 billion in 2026 to USD 5.40 billion by 2031, at a CAGR of 8.7%. This growth is driven by several key factors shaping the future of diagnostic technology, preventive care, and precision veterinary medicine.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2024-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | By Product, Technology, Application, Animal Type, End User, Region |
| Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
A key catalyst is the growing need for sophisticated diagnostic platforms as veterinary healthcare organizations seek to improve the accuracy, speed, and efficiency of current diagnostic processes. With the increasing need for a targeted, data-focused approach in companion animal healthcare, demand for high-quality diagnostic platforms is rising. Moreover, the need to shift focus to preventive healthcare and targeted disease management is being fueled by the growing demand for innovative diagnostic platforms. This trend is being augmented by AI-driven data analysis and cloud services, resulting in demand for innovative GMP-compliant diagnostic platforms.
Furthermore, the increasing incidence of chronic, infectious, and age-related diseases in domesticated pets is fueling the need for rapid, efficient diagnostic options. Veterinarians and veterinary labs are increasingly seeking support from specialty diagnostic companies to meet the ever-rising volume of cases through high-throughput testing, molecular testing, and imaging capabilities. The growing momentum toward modernizing the field of vet care, driven by real-time monitoring tools, artificial intelligence-powered predictive analytics, and cloud-based systems, is also fueling the need for new, high-quality diagnostic services.
Advances in technology, including automated analyzers, point-of-care testing, and AI interpretation, are fueling the market by improving test accuracy and turnaround times and expanding testing available in the companion animal space. With more of the companion animal diagnostics space outsourcing expertise in complex animal diagnoses or animal research, these advances also support the continued evolution of the companion animal diagnostics market.
"By technology, molecular diagnostics segment to register the highest CAGR during forecast period."
The molecular diagnostics segment is expected to see the highest growth in the companion animal diagnostics market due to its ability to deliver accurate results for infectious diseases, genetic disorders, and cancers in pet animals. Improvements in PCR, next-generation sequencing, and liquid biopsy have increased the use of molecular diagnostics, enabling veterinarians to easily test their patients for complex ailments that were previously hard to identify. Additionally, there is a growing need for precision medicine, which requires precise diagnostic methods to provide tailored treatment plans for pets.
"By product, consumables segment accounted for larger market share in 2025."
In 2025, the consumables segment dominated the companion animal diagnostics market, as reagents, test kits, and diagnostic strips are indispensable components of most tests performed in veterinary labs and animal health centers. Those consumables are used in everyday tests conducted for companion animals, including blood and urinalysis tests. Point-of-care and in-house testing are also widely adopted in the companion animal industry, and these consumables are used on a day-to-day basis. Furthermore, as the need to test animals increases and vet practices move toward preventive testing, there will be a growing demand for consumables, thereby maintaining their dominant market position.
"Asia Pacific to witness highest growth rate during forecast period."
The Asia Pacific region is expected to witness the fastest growth in the companion animal diagnostics market during the forecast period, driven by the growing number of pet lovers who are spending heavily on their pets. With greater awareness of animal health and higher spending capacity among pet owners, the Asia Pacific market is growing rapidly. The increased use of advanced animal diagnostic equipment, such as point-of-care testing and molecular diagnostics, is meeting the need for high-quality diagnostics at affordable prices. Moreover, advances in animal healthcare infrastructure and animal insurance coverage are driving the animal diagnostics market in the Asia Pacific region.
Breakdown of supply-side primary interviews:
- By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
- By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
- By Region: North America (45%), Europe (15%), Asia Pacific (25%), Latin America (10%), and the Middle East & Africa (5%)
Breakdown of demand-side primary interviews:
- By End User: Diagnostic Laboratories (45%), Veterinary Hospitals & Clinics (30%), Veterinary Research Institutes & Universities (15%), and Home Care Settings (10%)
By Designation: Veterinary Clinicians (47%), Diagnostic Laboratory Directors/Managers (22%), R&D Directors/Product Development Heads (15%), and Others (16%)
- By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)
Research Coverage
The market study covers the companion animal diagnostics market in various segments. It aims to estimate the market size and growth potential by product, technology, application, animal type, end user, and region. The study also includes an in-depth competitive analysis of the market's key players, along with their company profiles, key observations on their products and business offerings, recent developments, and key market strategies.
Reasons to Buy Report
The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger share of the market. Firms that acquire the report can implement one or more of the five strategies outlined below.
This report provides insights into the following points:
- Analysis of key drivers (growth in the companion animal population, rising demand for pet insurance, and increased spending on animal healthcare), restraints (high cost of diagnostic devices, stringent regulations and lengthy approval processes for diagnostic products), opportunities (growing demand for rapid tests and portable instruments for POC diagnostics, integration of AI and ML for enhanced disease diagnosis), and challenges (shortage of veterinary practitioners in emerging markets, barriers to adoption in small clinics) influencing the growth of the companion animal diagnostics market.
- Product Development/Innovation: Detailed insights on upcoming technologies and product launches in the companion animal diagnostics market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of companion animal diagnostic products across regions.
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the companion animal diagnostics market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the companion animal diagnostics market.
Product Code: MD 7053
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.3.5 UNITS CONSIDERED
- 1.4 MARKET STAKEHOLDERS
- 1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
- 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS IN COMPANION ANIMAL DIAGNOSTICS MARKET
- 2.4 HIGH-GROWTH SEGMENTS
- 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 COMPANION ANIMAL DIAGNOSTICS MARKET OVERVIEW
- 3.2 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT & COUNTRY (2025)
- 3.3 COMPANION ANIMAL DIAGNOSTICS MARKET: REGIONAL MIX
- 3.4 COMPANION ANIMAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- 3.5 COMPANION ANIMAL DIAGNOSTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Growth in companion animal population
- 4.2.1.2 Increasing demand for pet insurance and growth in animal healthcare expenditure
- 4.2.1.3 Growing number of veterinary practitioners
- 4.2.1.4 Increasing prevalence of infectious, parasitic, and chronic diseases in pets
- 4.2.2 RESTRAINTS
- 4.2.2.1 Rising pet care costs
- 4.2.2.2 Limited access to advanced veterinary diagnostic services in developing regions
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Growing demand for rapid tests and portable instruments for POC diagnostics
- 4.2.3.2 Utilization of AI and ML for enhanced disease diagnosis
- 4.2.4 CHALLENGES
- 4.2.4.1 Low awareness regarding preventive diagnostics among pet owners in price-sensitive markets
- 4.2.4.2 Regulatory and reimbursement limitations in veterinary healthcare diagnostics
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS & WHITE SPACES
- 4.3.1 UNMET NEEDS IN COMPANION ANIMAL DIAGNOSTICS MARKET
- 4.3.2 WHITE SPACE OPPORTUNITIES
- 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
- 4.4.1 INTERCONNECTED MARKETS
- 4.4.2 CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
- 4.5.1 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 THREAT OF SUBSTITUTES
- 5.1.3 BARGAINING POWER OF SUPPLIERS
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.2 MACROECONOMIC INDICATORS
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS & FORECAST
- 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
- 5.2.4 TRENDS IN GLOBAL ANIMAL HEALTH INDUSTRY
- 5.3 VALUE CHAIN ANALYSIS
- 5.4 ECOSYSTEM ANALYSIS
- 5.5 PRICING ANALYSIS
- 5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023-2025
- 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION, 2023-2025
- 5.5.2.1 Average selling price trend of rapid test kits, by region, 2023-2025
- 5.5.2.2 Average selling price trend of ELISA/immunodiagnostic test kits & reagents, by region, 2023-2025
- 5.5.2.3 Average selling price trend of clinical chemistry reagents, clips & cartridges, by region, 2023-2025
- 5.5.2.4 Average selling price trend of blood glucose strips, by region, 2023-2025
- 5.5.2.5 Average selling price trend of hematology analyzers, by region, 2023-2025
- 5.6 TRADE ANALYSIS
- 5.6.1 TRADE DATA FOR HS CODE 9018
- 5.6.1.1 Import data for HS Code 9018
- 5.6.1.2 Export data for HS Code 9018
- 5.6.2 TRADE DATA FOR HS CODE 3822
- 5.6.2.1 Import data for HS Code 3822
- 5.6.2.2 Export data for HS Code 3822
- 5.6.1 TRADE DATA FOR HS CODE 9018
- 5.7 KEY CONFERENCES & EVENTS, 2026-2027
- 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.9 INVESTMENT & FUNDING SCENARIO
- 5.10 SUCCESS STORIES & REAL-WORLD APPLICATIONS
- 5.10.1 NGS-BASED LIQUID BIOPSY FOR CANINE CANCER DETECTION
- 5.10.2 ADOPTION OF AI-ENABLED POC DIAGNOSTIC PLATFORM FOR PARASITE DETECTION
- 5.10.3 DEVELOPMENT OF SNAP 4DX PLUS TEST FOR RAPID VECTOR-BORNE DISEASE DETECTION
- 5.11 IMPACT OF US TARIFFS-COMPANION ANIMAL DIAGNOSTICS MARKET
- 5.11.1 INTRODUCTION
- 5.11.2 KEY TARIFF RATES
- 5.11.3 PRICE IMPACT ANALYSIS
- 5.11.4 IMPACT ON COUNTRIES/REGIONS
- 5.11.5 IMPACT ON END-USE INDUSTRIES
- 5.11.5.1 Veterinary Hospitals & Clinics
- 5.11.5.2 Veterinary Reference Laboratories
- 5.11.5.3 Veterinary Research Institutes & Universities
- 5.11.5.4 Home Care Settings
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
- 6.1 KEY EMERGING TECHNOLOGIES
- 6.1.1 AI-ENABLED DIAGNOSTICS
- 6.1.2 PORTABLE INSTRUMENTS FOR POC DIAGNOSTIC SERVICES
- 6.2 COMPLEMENTARY TECHNOLOGIES
- 6.2.1 MICROFLUIDIC DEVICES FOR VETERINARY DIAGNOSTICS
- 6.2.2 CRISPR-BASED MOLECULAR DIAGNOSTICS
- 6.3 ADJACENT TECHNOLOGIES
- 6.3.1 WEARABLE BIOSENSORS & REMOTE MONITORING DEVICES
- 6.3.2 BREATH & SALIVA-BASED DIAGNOSTIC TOOLS
- 6.4 TECHNOLOGY/PRODUCT ROADMAP
- 6.4.1 NEAR TERM (2025-2027)
- 6.4.2 MID-TERM (2028-2030)
- 6.4.3 LONG TERM (2030+)
- 6.5 PATENT ANALYSIS
- 6.5.1 PATENT PUBLICATION TRENDS FOR COMPANION ANIMAL DIAGNOSTIC KITS
- 6.5.2 JURISDICTION & TOP APPLICANT ANALYSIS
- 6.6 FUTURE APPLICATIONS
- 6.6.1 AI-DRIVEN PREDICTIVE DIAGNOSTICS
- 6.6.2 FULLY INTEGRATED DIGITAL VETERINARY ECOSYSTEMS
- 6.6.3 PRECISION & PERSONALIZED VETERINARY DIAGNOSTICS
- 6.6.4 REMOTE & HOME-BASED PET HEALTH MONITORING
- 6.6.5 AUTOMATED HIGH-THROUGHPUT VETERINARY LABORATORIES
- 6.7 IMPACT OF AI/GENERATIVE AI ON COMPANION ANIMAL DIAGNOSTICS MARKET
- 6.7.1 INTRODUCTION
- 6.7.2 MARKET POTENTIAL IN COMPANION ANIMAL DIAGNOSTIC ECOSYSTEM
- 6.7.3 AI USE CASES
- 6.7.4 KEY COMPANIES IMPLEMENTING AI IN COMPANION ANIMAL DIAGNOSTICS MARKET
7 REGULATORY LANDSCAPE & SUSTAINABILITY INITIATIVES
- 7.1 REGIONAL REGULATIONS & COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.1.1 North America
- 7.1.1.2 Europe
- 7.1.1.3 Rest of the world
- 7.1.2 INDUSTRY STANDARDS
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.2 SUSTAINABILITY INITIATIVES
- 7.2.1 RECYCLED AND ECO-FRIENDLY MATERIALS FOR COMPANION ANIMAL DIAGNOSTIC PRODUCTS
- 7.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
- 7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 8.1 KEY STAKEHOLDERS & BUYING CRITERIA
- 8.1.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.1.2 BUYING CRITERIA
- 8.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 8.2.1 DECISION-MAKING PROCESS
- 8.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 8.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
- 8.2.4 MARKET PROFITABILITY
9 COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT
- 9.1 INTRODUCTION
- 9.2 CONSUMABLES
- 9.2.1 RECURRING NATURE TO BOOST DEMAND
- 9.3 INSTRUMENTS
- 9.3.1 INCREASING DEMAND FOR POC ANALYZERS TO DRIVE MARKET
10 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY
- 10.1 INTRODUCTION
- 10.2 IMMUNODIAGNOSTICS
- 10.2.1 LATERAL FLOW ASSAYS
- 10.2.1.1 Rapid tests
- 10.2.1.1.1 Growing prevalence of infectious diseases in pets to fuel demand
- 10.2.1.1.2 Global volume analysis of rapid tests, 2024-2031 (thousand units)
- 10.2.1.2 Strip readers
- 10.2.1.2.1 Advancements in digital and AI-enabled diagnostics to support adoption
- 10.2.1.2.2 Global volume analysis of strip readers, 2024-2031 (thousand units)
- 10.2.1.1 Rapid tests
- 10.2.2 ELISA TESTS
- 10.2.2.1 Higher sensitivity and specificity of ELISA testing to support market expansion
- 10.2.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
- 10.2.3.1 Rising incidence of allergies and dermatological conditions to fuel market growth
- 10.2.4 IMMUNOASSAY ANALYZERS
- 10.2.4.1 Increasing automation in veterinary diagnostics to drive market growth
- 10.2.5 RADIOIMMUNOASSAYS
- 10.2.5.1 Growing demand for sensitive hormone and endocrine testing to fuel market
- 10.2.6 OTHER IMMUNODIAGNOSTICS PRODUCTS
- 10.2.1 LATERAL FLOW ASSAYS
- 10.3 CLINICAL BIOCHEMISTRY
- 10.3.1 CLINICAL CHEMISTRY ANALYSIS
- 10.3.1.1 Clinical chemistry reagents, clips, and cartridges
- 10.3.1.1.1 Increasing utilization of consumable-based diagnostic workflows to fuel market
- 10.3.1.1.2 Global volume analysis of clinical chemistry reagents, clips, and cartridges, 2024-2031 (thousand units)
- 10.3.1.2 Clinical chemistry analyzers
- 10.3.1.2.1 Growing adoption of in-house veterinary diagnostics to drive analyzer demand
- 10.3.1.2.2 Global volume analysis of clinical chemistry analyzers, 2024-2031 (thousand units)
- 10.3.1.1 Clinical chemistry reagents, clips, and cartridges
- 10.3.2 BLOOD GAS & ELECTROLYTE ANALYSIS
- 10.3.2.1 Blood gas and electrolyte reagents, clips, and cartridges
- 10.3.2.1.1 Rising demand for rapid point-of-care consumables to boost market
- 10.3.2.1.2 Global volume analysis of blood gas & electrolyte reagents, clips, and cartridges, 2024-2031 (thousand units)
- 10.3.2.2 Blood gas & electrolyte analyzers
- 10.3.2.2.1 Increasing adoption of compact critical-care analyzers in veterinary clinics to drive market
- 10.3.2.2.2 Global volume analysis of blood gas & electrolyte analyzers, 2024-2031 (thousand units)
- 10.3.2.1 Blood gas and electrolyte reagents, clips, and cartridges
- 10.3.3 GLUCOSE MONITORING
- 10.3.3.1 Blood glucose strips
- 10.3.3.1.1 Increasing home-based diabetes management to fuel market
- 10.3.3.1.2 Global volume analysis of blood glucose strips, 2024-2031 (thousand units)
- 10.3.3.2 Glucose monitors
- 10.3.3.2.1 Advancements in portable and continuous glucose monitoring technologies to drive market growth
- 10.3.3.2.2 Global volume analysis of glucose monitors, 2024-2031 (thousand units)
- 10.3.3.3 Urine glucose strips
- 10.3.3.3.1 Cost-effective and non-invasive diabetes screening to propel market
- 10.3.3.3.2 Global volume analysis of urine glucose strips, 2024-2031 (thousand units)
- 10.3.3.1 Blood glucose strips
- 10.3.1 CLINICAL CHEMISTRY ANALYSIS
- 10.4 MOLECULAR DIAGNOSTICS
- 10.4.1 PCR TESTS
- 10.4.1.1 Increasing prevalence of infectious diseases in companion animals to support growth
- 10.4.2 MICROARRAYS
- 10.4.2.1 Growing focus on genomic profiling and multiplex testing to drive market
- 10.4.3 NUCLEIC ACID SEQUENCING
- 10.4.3.1 Expanding applications of genomic analysis in veterinary medicine to drive demand
- 10.4.4 OTHER MOLECULAR DIAGNOSTICS PRODUCTS
- 10.4.1 PCR TESTS
- 10.5 URINALYSIS
- 10.5.1 URINALYSIS CLIPS & CARTRIDGES
- 10.5.1.1 Growing use of consumable-based urine testing workflows to drive growth
- 10.5.2 URINE ANALYZERS
- 10.5.2.1 Increasing automation in veterinary urinalysis testing to support market growth
- 10.5.3 URINE TEST STRIPS
- 10.5.3.1 Rising demand for rapid and cost-effective urine screening tests to drive market
- 10.5.1 URINALYSIS CLIPS & CARTRIDGES
- 10.6 HEMATOLOGY
- 10.6.1 HEMATOLOGY CARTRIDGES
- 10.6.1.1 Rising use of disposable consumables in automated hematology workflows to fuel demand
- 10.6.2 HEMATOLOGY ANALYZERS
- 10.6.2.1 Growing demand for rapid complete blood count testing to support market growth
- 10.6.1 HEMATOLOGY CARTRIDGES
- 10.7 OTHER TECHNOLOGIES
11 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION
- 11.1 INTRODUCTION
- 11.2 CLINICAL PATHOLOGY
- 11.2.1 INCREASING PREVENTIVE HEALTH SCREENING AND CHRONIC DISEASE MONITORING DRIVES DEMAND
- 11.3 BACTERIOLOGY
- 11.3.1 RISING BACTERIAL INFECTIONS AND ANTIMICROBIAL RESISTANCE CONCERNS BOOST MARKET GROWTH
- 11.4 VIROLOGY
- 11.4.1 GROWING PREVALENCE OF COMPANION ANIMAL VIRAL DISEASES DRIVES GROWTH
- 11.5 PARASITOLOGY
- 11.5.1 INCREASING PARASITIC AND VECTOR-BORNE DISEASE BURDEN SUPPORTS DIAGNOSTIC ADOPTION
- 11.6 OTHER APPLICATIONS
12 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE
- 12.1 INTRODUCTION
- 12.2 DOGS
- 12.2.1 RISING PREVALENCE OF CANINE CHRONIC AND VECTOR-BORNE DISEASES DRIVES DIAGNOSTIC DEMAND
- 12.3 CATS
- 12.3.1 GROWING AWARENESS OF FELINE INFECTIOUS AND KIDNEY DISEASES BOOSTS MARKET GROWTH
- 12.4 HORSE
- 12.4.1 INCREASING EQUINE HEALTH MONITORING SUPPORTS DIAGNOSTIC ADOPTION
- 12.5 OTHER COMPANION ANIMALS
13 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER
- 13.1 INTRODUCTION
- 13.2 VETERINARY HOSPITALS & CLINICS
- 13.2.1 EXPANDING ADOPTION OF IN-HOUSE POINT-OF-CARE DIAGNOSTIC SOLUTIONS TO DRIVE MARKET
- 13.3 VETERINARY REFERENCE LABORATORIES
- 13.3.1 RISING DEMAND FOR SPECIALIZED AND HIGH-COMPLEXITY VETERINARY DIAGNOSTIC TESTING TO PROPEL MARKET
- 13.4 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
- 13.4.1 INCREASING RESEARCH FOCUS ON PRECISION AND MOLECULAR VETERINARY DIAGNOSTICS TO SUPPORT GROWTH
- 13.5 HOME CARE SETTINGS
- 13.5.1 GROWING ADOPTION OF AT-HOME PET HEALTH MONITORING AND DIAGNOSTIC TECHNOLOGIES TO BOOST DEMAND
14 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION
- 14.1 INTRODUCTION
- 14.2 NORTH AMERICA
- 14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 14.2.2 NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024-2031
- 14.2.3 US
- 14.2.3.1 Rising preventive pet healthcare spending to drive market
- 14.2.4 CANADA
- 14.2.4.1 Increasing veterinary visits and growing pet population to drive market
- 14.3 EUROPE
- 14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 14.3.2 EUROPE: VOLUME ANALYSIS, BY PRODUCT, 2024-2031
- 14.3.3 GERMANY
- 14.3.3.1 Large companion animal population and premium veterinary care fuel market growth
- 14.3.4 UK
- 14.3.4.1 High veterinary expenditure and rising chronic pet diseases support diagnostics demand
- 14.3.5 FRANCE
- 14.3.5.1 Willingness of pet owners to spend on pet health to drive market
- 14.3.6 ITALY
- 14.3.6.1 Expansion of veterinary services supports market growth
- 14.3.7 SPAIN
- 14.3.7.1 Growing pet care economy and animal welfare initiatives to fuel market
- 14.3.8 NETHERLANDS
- 14.3.8.1 Developments in veterinary diagnostic products to support market growth
- 14.3.9 SWEDEN
- 14.3.9.1 Growing companion animal care and advanced veterinary infrastructure supporting market growth
- 14.3.10 POLAND
- 14.3.10.1 Expanding veterinary infrastructure and rising pet ownership support market development
- 14.3.11 REST OF EUROPE
- 14.4 ASIA PACIFIC
- 14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 14.4.2 ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT, 2024-2031
- 14.4.3 CHINA
- 14.4.3.1 Growing urban pet population and rising adoption of pet insurance to propel market
- 14.4.4 JAPAN
- 14.4.4.1 Aging pet population and premium veterinary care to support market growth
- 14.4.5 INDIA
- 14.4.5.1 Expanding pet care industry and rising preventive healthcare awareness fuel market growth
- 14.4.6 AUSTRALIA
- 14.4.6.1 High veterinary expenditure and strong pet insurance penetration to support market growth
- 14.4.7 SOUTH KOREA
- 14.4.7.1 Digital veterinary healthcare expansion to drive market
- 14.4.8 THAILAND
- 14.4.8.1 Urban pet adoption and improving veterinary infrastructure to drive market
- 14.4.9 NEW ZEALAND
- 14.4.9.1 Strong animal welfare culture and preventive care trends support market expansion
- 14.4.10 REST OF ASIA PACIFIC
- 14.5 LATIN AMERICA
- 14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 14.5.2 LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024-2031
- 14.5.3 BRAZIL
- 14.5.3.1 Massive companion animal population to boost demand
- 14.5.4 MEXICO
- 14.5.4.1 High pet ownership and expanding veterinary services to support market growth
- 14.5.5 ARGENTINA
- 14.5.5.1 Strong pet humanization and preventive healthcare trends support market growth
- 14.5.6 REST OF LATIN AMERICA
- 14.6 MIDDLE EAST & AFRICA
- 14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 14.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT, 2024-2031
- 14.6.3 GCC COUNTRIES
- 14.6.3.1 Kingdom of Saudi Arabia (KSA)
- 14.6.3.1.1 Government initiatives to drive market growth
- 14.6.3.2 United Arab Emirates (UAE)
- 14.6.3.2.1 Premium veterinary services and rising pet ownership to drive market
- 14.6.3.3 Rest of GCC Countries
- 14.6.3.1 Kingdom of Saudi Arabia (KSA)
- 14.6.4 REST OF MIDDLE EAST & AFRICA
15 COMPETITIVE LANDSCAPE
- 15.1 OVERVIEW
- 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 15.3 REVENUE ANALYSIS, 2021-2025
- 15.4 MARKET SHARE ANALYSIS, 2025
- 15.4.1 RANKING OF KEY MARKET PLAYERS
- 15.4.2 US MARKET SHARE ANALYSIS, 2025
- 15.4.3 EUROPE MARKET SHARE ANALYSIS, 2025
- 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 15.5.1 STARS
- 15.5.2 EMERGING LEADERS
- 15.5.3 PERVASIVE PLAYERS
- 15.5.4 PARTICIPANTS
- 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 15.5.5.1 Company footprint
- 15.5.5.2 Region footprint
- 15.5.5.3 Product footprint
- 15.5.5.4 Technology footprint
- 15.5.5.5 Animal type footprint
- 15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 15.6.1 PROGRESSIVE COMPANIES
- 15.6.2 RESPONSIVE COMPANIES
- 15.6.3 DYNAMIC COMPANIES
- 15.6.4 STARTING BLOCKS
- 15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
- 15.6.5.1 Detailed list of key startups/SMEs
- 15.6.5.2 Competitive benchmarking of key startups
- 15.7 BRAND/PRODUCT COMPARISON
- 15.8 R&D EXPENDITURE OF KEY PLAYERS
- 15.9 COMPANY VALUATION & FINANCIAL METRICS
- 15.9.1 FINANCIAL METRICS
- 15.9.2 COMPANY VALUATION
- 15.10 COMPETITIVE SCENARIO
- 15.10.1 PRODUCT LAUNCHES & ENHANCEMENTS
- 15.10.2 DEALS
- 15.10.3 EXPANSIONS
- 15.10.4 OTHER DEVELOPMENTS
16 COMPANY PROFILES
- 16.1 KEY PLAYERS
- 16.1.1 IDEXX LABORATORIES, INC.
- 16.1.1.1 Business overview
- 16.1.1.2 Products offered
- 16.1.1.3 Recent developments
- 16.1.1.3.1 Product launches & enhancements
- 16.1.1.4 MnM view
- 16.1.1.4.1 Key strengths
- 16.1.1.4.2 Strategic choices
- 16.1.1.4.3 Weaknesses & competitive threats
- 16.1.2 ANTECH DIAGNOSTICS, INC.
- 16.1.2.1 Business overview
- 16.1.2.2 Products offered
- 16.1.2.3 Recent developments
- 16.1.2.3.1 Product launches & approvals
- 16.1.2.3.2 Expansions
- 16.1.2.4 MnM view
- 16.1.2.4.1 Key strengths
- 16.1.2.4.2 Strategic choices
- 16.1.2.4.3 Weaknesses & competitive threats
- 16.1.3 ZOETIS SERVICES LLC
- 16.1.3.1 Business overview
- 16.1.3.2 Products offered
- 16.1.3.3 Recent developments
- 16.1.3.3.1 Product launches & enhancements
- 16.1.3.3.2 Deals
- 16.1.3.3.3 Expansions
- 16.1.3.3.4 Other developments
- 16.1.3.4 MnM view
- 16.1.3.4.1 Key strengths
- 16.1.3.4.2 Strategic choices
- 16.1.3.4.3 Weaknesses & competitive threats
- 16.1.4 FUJIFILM CORPORATION
- 16.1.4.1 Business overview
- 16.1.4.2 Products offered
- 16.1.4.3 MnM view
- 16.1.4.3.1 Key strengths
- 16.1.4.3.2 Strategic choices
- 16.1.4.3.3 Weaknesses & competitive threats
- 16.1.5 THERMO FISHER SCIENTIFIC INC.
- 16.1.5.1 Business overview
- 16.1.5.2 Products offered
- 16.1.5.3 MnM view
- 16.1.5.3.1 Key strengths
- 16.1.5.3.2 Strategic choices
- 16.1.5.3.3 Weaknesses & competitive threats
- 16.1.6 BIOMERIEUX
- 16.1.6.1 Business overview
- 16.1.6.2 Products offered
- 16.1.6.3 Recent developments
- 16.1.6.3.1 Product launches & approvals
- 16.1.7 BIONOTE
- 16.1.7.1 Business overview
- 16.1.7.2 Products offered
- 16.1.7.3 Recent developments
- 16.1.7.3.1 Product launches & enhancements
- 16.1.7.3.2 Deals
- 16.1.8 VIRBAC
- 16.1.8.1 Business overview
- 16.1.8.2 Products offered
- 16.1.8.3 Recent developments
- 16.1.8.3.1 Deals
- 16.1.8.3.2 Expansions
- 16.1.9 RANDOX LABORATORIES LTD.
- 16.1.9.1 Business overview
- 16.1.9.2 Products offered
- 16.1.9.3 Recent developments
- 16.1.9.3.1 Deals
- 16.1.9.3.2 Expansions
- 16.1.10 INDICAL BIOSCIENCE GMBH
- 16.1.10.1 Business overview
- 16.1.10.2 Products offered
- 16.1.10.3 Recent developments
- 16.1.10.3.1 Product enhancements
- 16.1.11 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
- 16.1.11.1 Business overview
- 16.1.11.2 Products offered
- 16.1.11.3 Recent developments
- 16.1.11.3.1 Product launches
- 16.1.11.3.2 Expansions
- 16.1.12 BOULE
- 16.1.12.1 Business overview
- 16.1.12.2 Products offered
- 16.1.12.3 Recent developments
- 16.1.12.3.1 Product launches
- 16.1.12.3.2 Deals
- 16.1.13 INNOVATIVE DIAGNOSTICS
- 16.1.13.1 Business overview
- 16.1.13.2 Products offered
- 16.1.13.3 Recent developments
- 16.1.13.3.1 Other developments
- 16.1.14 MEGACOR DIAGNOSTIK GMBH
- 16.1.14.1 Business overview
- 16.1.14.2 Products offered
- 16.1.14.3 Recent developments
- 16.1.14.3.1 Product launches & enhancements
- 16.1.15 BIOGAL
- 16.1.15.1 Business overview
- 16.1.15.2 Products offered
- 16.1.1 IDEXX LABORATORIES, INC.
- 16.2 OTHER PLAYERS
- 16.2.1 GOLD STANDARD DIAGNOSTICS
- 16.2.2 AGROLABO S.P.A.
- 16.2.3 PRECISION BIOSENSOR, INC.
- 16.2.4 SKYLA CORPORATION
- 16.2.5 FASSISI, GMBH
- 16.2.6 WOODLEY EQUIPMENT COMPANY LTD
- 16.2.7 BIOPANDA REAGENTS LTD
- 16.2.8 SKYER, INC.
- 16.2.9 RING BIOTECHNOLOGY CO., LTD.
- 16.2.10 SHENZHEN BIOEASY BIOTECHNOLOGY, INC.
17 RESEARCH METHODOLOGY
- 17.1 RESEARCH DATA
- 17.2 RESEARCH METHODOLOGY DESIGN
- 17.2.1 SECONDARY DATA
- 17.2.1.1 Key data from secondary sources
- 17.2.2 PRIMARY DATA
- 17.2.2.1 Key data from primary sources
- 17.2.2.2 Key industry insights
- 17.2.1 SECONDARY DATA
- 17.3 MARKET SIZE ESTIMATION
- 17.3.1 BOTTOM-UP APPROACH
- 17.4 MARKET BREAKDOWN AND DATA TRIANGULATION
- 17.5 MARKET SHARE ANALYSIS
- 17.5.1 RESEARCH ASSUMPTIONS
- 17.5.2 GROWTH RATE ASSUMPTIONS
- 17.6 RISK ASSESSMENT
- 17.7 RESEARCH LIMITATIONS
- 17.7.1 METHODOLOGY-RELATED LIMITATIONS
- 17.7.2 SCOPE-RELATED LIMITATIONS
18 APPENDIX
- 18.1 DISCUSSION GUIDE
- 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 18.3 CUSTOMIZATION OPTIONS
- 18.3.1 PRODUCT ANALYSIS
- 18.3.2 COMPANY INFORMATION
- 18.3.3 GEOGRAPHIC ANALYSIS
- 18.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
- 18.3.5 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT
- 18.3.6 BY PRODUCT MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
- 18.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
- 18.4 RELATED REPORTS
- 18.5 AUTHOR DETAILS
Product Code: MD 7053
List of Tables
- TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
- TABLE 2 NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2025, BY ANIMAL TYPE (MILLIONS)
- TABLE 3 AVERAGE PREMIUMS PAID IN US, 2023 VS. 2024
- TABLE 4 COMPANION ANIMAL DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
- TABLE 5 GDP CHANGE, BY KEY COUNTRY, 2021-2030 (USD BILLION)
- TABLE 6 AVERAGE SELLING PRICE TREND OF COMPANION ANIMAL DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023-2025 (USD)
- TABLE 7 AVERAGE SELLING PRICE TREND OF RAPID TEST KITS, BY REGION, 2023-2025
- TABLE 8 AVERAGE SELLING PRICE TREND OF ELISA/IMMUNODIAGNOSTIC TEST KITS & REAGENTS, BY REGION, 2023-2025
- TABLE 9 AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES, BY REGION, 2023-2025
- TABLE 10 AVERAGE SELLING PRICE TREND OF BLOOD GLUCOSE STRIPS, BY REGION, 2023-2025
- TABLE 11 AVERAGE SELLING PRICE TREND OF HEMATOLOGY ANALYZERS, BY REGION, 2023-2025
- TABLE 12 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2021-2025 (USD THOUSAND)
- TABLE 13 EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2021-2025 (USD THOUSAND)
- TABLE 14 IMPORT DATA FOR HS CODE 3822, BY COUNTRY, 2021-2025 (USD THOUSAND)
- TABLE 15 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2021-2025 (USD THOUSAND)
- TABLE 16 COMPANION ANIMAL DIAGNOSTICS MARKET: MAJOR CONFERENCES & EVENTS IN 2026-2027
- TABLE 17 CASE STUDY 1: NGS-BASED LIQUID BIOPSY FOR CANINE CANCER DETECTION
- TABLE 18 CASE STUDY 2: ADOPTION OF AI -ENABLED POC DIAGNOSTIC PLATFORM FOR PARASITE DETECTION
- TABLE 19 CASE STUDY 3: MULTIPLEX ELISA-BASED POC DIAGNOSTIC TEST: TARGETING VECTOR-BORNE DISEASE DETECTION
- TABLE 20 US-ADJUSTED RECIPROCAL TARIFF RATES
- TABLE 21 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR COMPANION ANIMAL DIAGNOSTICS
- TABLE 22 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
- TABLE 23 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
- TABLE 24 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS
- TABLE 25 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
- TABLE 26 COMPANION ANIMAL DIAGNOSTICS MARKET: MAJOR PATENTS
- TABLE 27 KEY COMPANIES IMPLEMENTING AI IN COMPANION ANIMAL DIAGNOSTICS MARKET
- TABLE 28 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 29 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 30 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR COMPANION ANIMAL DIAGNOSTICS PRODUCTS
- TABLE 32 KEY BUYING CRITERIA FOR TOP THREE END USERS
- TABLE 33 COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 34 KEY PLAYERS OFFERING COMPANION ANIMAL DIAGNOSTIC CONSUMABLES
- TABLE 35 COMPANION ANIMAL DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 36 KEY PLAYERS PROVIDING COMPANION ANIMAL DIAGNOSTIC INSTRUMENTS
- TABLE 37 COMPANION ANIMAL DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 38 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 39 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES
- TABLE 40 COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 41 COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 42 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS
- TABLE 43 LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 44 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 45 KEY PLAYERS PROVIDING LATERAL FLOW RAPID TESTS
- TABLE 46 RAPID TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 47 RAPID TESTS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
- TABLE 48 KEY PLAYERS PROVIDING LATERAL FLOW STRIP READERS
- TABLE 49 STRIP READERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 50 STRIP READERS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
- TABLE 51 KEY PLAYERS PROVIDING ELISA TESTS
- TABLE 52 ELISA TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 53 KEY PLAYERS PROVIDING ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
- TABLE 54 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 55 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS
- TABLE 56 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 57 KEY PLAYERS PROVIDING RADIOIMMUNOASSAYS
- TABLE 58 RADIOIMMUNOASSAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 59 OTHER IMMUNODIAGNOSTICS PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 60 KEY PLAYERS PROVIDING CLINICAL BIOCHEMISTRY PRODUCTS
- TABLE 61 COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 62 COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 63 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY ANALYSIS
- TABLE 64 CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 65 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 66 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES
- TABLE 67 CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 68 CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
- TABLE 69 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY ANALYZERS
- TABLE 70 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 71 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
- TABLE 72 KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE ANALYSIS
- TABLE 73 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 74 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 75 KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE REAGENTS, CLIPS, AND CARTRIDGES
- TABLE 76 BLOOD GAS & ELECTROLYTE REAGENTS, CLIPS, AND CARTRIDGES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 77 BLOOD GAS & ELECTROLYTE REAGENTS, CLIPS, AND CARTRIDGES MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
- TABLE 78 KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE ANALYZERS
- TABLE 79 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 80 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
- TABLE 81 KEY PLAYERS PROVIDING GLUCOSE MONITORING
- TABLE 82 GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 83 GLUCOSE MONITORING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 84 KEY PLAYERS PROVIDING BLOOD GLUCOSE STRIPS
- TABLE 85 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 86 BLOOD GLUCOSE STRIPS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
- TABLE 87 KEY PLAYERS PROVIDING GLUCOSE MONITORS
- TABLE 88 GLUCOSE MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 89 GLUCOSE MONITORS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
- TABLE 90 KEY PLAYERS PROVIDING URINE GLUCOSE STRIPS
- TABLE 91 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 92 URINE GLUCOSE STRIPS MARKET, BY REGION, 2024-2031 (THOUSAND UNITS)
- TABLE 93 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS
- TABLE 94 COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 95 COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 96 KEY PLAYERS PROVIDING PCR TESTS
- TABLE 97 PCR TESTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 98 MICROARRAYS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 99 NUCLEIC ACID SEQUENCING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 100 OTHER MOLECULAR DIAGNOSTICS PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 101 KEY PLAYERS PROVIDING URINALYSIS PRODUCTS
- TABLE 102 COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 103 COMPANION ANIMAL URINALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 104 KEY PLAYERS PROVIDING URINALYSIS CLIPS & CARTRIDGES
- TABLE 105 URINALYSIS CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 106 KEY PLAYERS PROVIDING URINE ANALYZERS
- TABLE 107 URINE ANALYZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 108 KEY PLAYERS PROVIDING URINE TEST STRIPS
- TABLE 109 URINE TEST STRIPS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 110 KEY PLAYERS PROVIDING HEMATOLOGY PRODUCTS
- TABLE 111 COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 112 COMPANION ANIMAL HEMATOLOGY MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 113 KEY PLAYERS PROVIDING HEMATOLOGY CARTRIDGES
- TABLE 114 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 115 KEY PLAYERS PROVIDING HEMATOLOGY ANALYZERS
- TABLE 116 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 117 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES
- TABLE 118 OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 119 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 120 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CLINICAL PATHOLOGY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 121 COMPANION ANIMAL DIAGNOSTICS MARKET FOR BACTERIOLOGY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 122 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VIROLOGY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 123 COMPANION ANIMAL DIAGNOSTICS MARKET FOR PARASITOLOGY, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 124 COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 125 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 126 KEY PLAYERS OFFERING COMPANION ANIMAL DIAGNOSTIC PRODUCTS FOR DOGS
- TABLE 127 COMPANION ANIMAL DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 128 KEY PLAYERS OFFERING COMPANION ANIMAL DIAGNOSTIC PRODUCTS FOR CATS
- TABLE 129 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 130 KEY PLAYERS OFFERING COMPANION ANIMAL DIAGNOSTIC PRODUCTS FOR HORSES
- TABLE 131 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 132 COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 133 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 134 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 135 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 136 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 137 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 138 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 139 COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 140 NORTH AMERICA: VOLUME ANALYSIS OF COMPANION ANIMAL DIAGNOSTIC PRODUCTS, 2024-2031 (THOUSAND UNITS)
- TABLE 141 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 142 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 143 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 144 NORTH AMERICA: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 145 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 146 NORTH AMERICA: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 147 NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 148 NORTH AMERICA: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 149 NORTH AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 150 NORTH AMERICA: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 151 NORTH AMERICA: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 152 NORTH AMERICA: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 153 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 154 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 155 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 156 US: KEY MACROINDICATORS
- TABLE 157 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 158 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 159 US: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 160 US: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 161 US: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 162 US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 163 US: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 164 US: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 165 US: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 166 US: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 167 US: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 168 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 169 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 170 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 171 CANADA: KEY MACROINDICATORS
- TABLE 172 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 173 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 174 CANADA: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 175 CANADA: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 176 CANADA: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 177 CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 178 CANADA: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 179 CANADA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 180 CANADA: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 181 CANADA: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 182 CANADA: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 183 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 184 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 185 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 186 EUROPE: VOLUME ANALYSIS OF COMPANION ANIMAL DIAGNOSTIC PRODUCTS, 2024-2031 (THOUSAND UNITS)
- TABLE 187 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 188 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 189 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 190 EUROPE: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 191 EUROPE: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 192 EUROPE: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 193 EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 194 EUROPE: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 195 EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 196 EUROPE: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 197 EUROPE: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 198 EUROPE: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 199 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 200 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 201 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 202 GERMANY: KEY MACROINDICATORS
- TABLE 203 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 204 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 205 GERMANY: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 206 GERMANY: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 207 GERMANY: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 208 GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 209 GERMANY: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 210 GERMANY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 211 GERMANY: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 212 GERMANY: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 213 GERMANY: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 214 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 215 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 216 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 217 UK: KEY MACROINDICATORS
- TABLE 218 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 219 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 220 UK: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 221 UK: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 222 UK: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 223 UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 224 UK: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 225 UK: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 226 UK: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 227 UK: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 228 UK: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 229 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 230 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 231 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 232 FRANCE: KEY MACROINDICATORS
- TABLE 233 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 234 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 235 FRANCE: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 236 FRANCE: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 237 FRANCE: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 238 FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 239 FRANCE: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 240 FRANCE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 241 FRANCE: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 242 FRANCE: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 243 FRANCE: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 244 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 245 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 246 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 247 ITALY: KEY MACROINDICATORS
- TABLE 248 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 249 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 250 ITALY: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 251 ITALY: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 252 ITALY: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 253 ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 254 ITALY: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 255 ITALY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 256 ITALY: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 257 ITALY: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 258 ITALY: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 259 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 260 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 261 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 262 SPAIN: KEY MACROINDICATORS
- TABLE 263 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 264 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 265 SPAIN: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 266 SPAIN: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 267 SPAIN: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 268 SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 269 SPAIN: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 270 SPAIN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 271 SPAIN: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 272 SPAIN: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 273 SPAIN: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 274 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 275 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 276 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 277 NETHERLANDS: KEY MACROINDICATORS
- TABLE 278 NETHERLANDS: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 279 NETHERLANDS: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 280 NETHERLANDS: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 281 NETHERLANDS: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 282 NETHERLANDS: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 283 NETHERLANDS: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 284 NETHERLANDS: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 285 NETHERLANDS: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 286 NETHERLANDS: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 287 NETHERLANDS: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 288 NETHERLANDS: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 289 NETHERLANDS: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 290 NETHERLANDS: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 291 NETHERLANDS: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 292 SWEDEN: KEY MACROINDICATORS
- TABLE 293 SWEDEN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 294 SWEDEN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 295 SWEDEN: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 296 SWEDEN: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 297 SWEDEN: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 298 SWEDEN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 299 SWEDEN: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 300 SWEDEN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 301 SWEDEN: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 302 SWEDEN: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 303 SWEDEN: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 304 SWEDEN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 305 SWEDEN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 306 SWEDEN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 307 POLAND: KEY MACROINDICATORS
- TABLE 308 POLAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 309 POLAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 310 POLAND: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 311 POLAND: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 312 POLAND: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 313 POLAND: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 314 POLAND: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 315 POLAND: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 316 POLAND: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 317 POLAND: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 318 POLAND: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 319 POLAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 320 POLAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 321 POLAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 322 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 323 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 324 REST OF EUROPE: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 325 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 326 REST OF EUROPE: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 327 REST OF EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 328 REST OF EUROPE: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 329 REST OF EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 330 REST OF EUROPE: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 331 REST OF EUROPE: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 332 REST OF EUROPE: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 333 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 334 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 335 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 336 ASIA PACIFIC: VOLUME ANALYSIS OF COMPANION ANIMAL DIAGNOSTIC PRODUCTS, 2024-2031 (THOUSAND UNITS)
- TABLE 337 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 338 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 339 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 340 ASIA PACIFIC: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 341 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 342 ASIA PACIFIC: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 343 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 344 ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 345 ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 346 ASIA PACIFIC: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 347 ASIA PACIFIC: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 348 ASIA PACIFIC: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 349 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 350 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 351 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 352 CHINA: KEY MACROINDICATORS
- TABLE 353 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 354 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 355 CHINA: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 356 CHINA: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 357 CHINA: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 358 CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 359 CHINA: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 360 CHINA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 361 CHINA: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 362 CHINA: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 363 CHINA: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 364 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 365 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 366 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 367 JAPAN: KEY MACROINDICATORS
- TABLE 368 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 369 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 370 JAPAN: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 371 JAPAN: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 372 JAPAN: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 373 JAPAN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 374 JAPAN: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 375 JAPAN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 376 JAPAN: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 377 JAPAN: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 378 JAPAN: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 379 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 380 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 381 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 382 INDIA: KEY MACROINDICATORS
- TABLE 383 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 384 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 385 INDIA: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 386 INDIA: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 387 INDIA: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 388 INDIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 389 INDIA: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 390 INDIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 391 INDIA: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 392 INDIA: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 393 INDIA: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 394 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 395 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 396 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 397 AUSTRALIA: KEY MACROINDICATORS
- TABLE 398 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 399 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 400 AUSTRALIA: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 401 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 402 AUSTRALIA: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 403 AUSTRALIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 404 AUSTRALIA: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 405 AUSTRALIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 406 AUSTRALIA: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 407 AUSTRALIA: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 408 AUSTRALIA: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 409 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 410 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 411 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 412 SOUTH KOREA: KEY MACROINDICATORS
- TABLE 413 SOUTH KOREA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 414 SOUTH KOREA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 415 SOUTH KOREA: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 416 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 417 SOUTH KOREA: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 418 SOUTH KOREA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 419 SOUTH KOREA: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 420 SOUTH KOREA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 421 SOUTH KOREA: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 422 SOUTH KOREA: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 423 SOUTH KOREA: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 424 SOUTH KOREA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 425 SOUTH KOREA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 426 SOUTH KOREA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 427 THAILAND: KEY MACROINDICATORS
- TABLE 428 THAILAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 429 THAILAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 430 THAILAND: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 431 THAILAND: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 432 THAILAND: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 433 THAILAND: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 434 THAILAND: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 435 THAILAND: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 436 THAILAND: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 437 THAILAND: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 438 THAILAND: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 439 THAILAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 440 THAILAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 441 THAILAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 442 NEW ZEALAND: KEY MACROINDICATORS
- TABLE 443 NEW ZEALAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 444 NEW ZEALAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 445 NEW ZEALAND: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 446 NEW ZEALAND: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 447 NEW ZEALAND: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 448 NEW ZEALAND: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 449 NEW ZEALAND: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 450 NEW ZEALAND: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 451 NEW ZEALAND: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 452 NEW ZEALAND: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 453 NEW ZEALAND: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 454 NEW ZEALAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 455 NEW ZEALAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 456 NEW ZEALAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 457 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 458 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 459 REST OF ASIA PACIFIC: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 460 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 461 REST OF ASIA PACIFIC: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 462 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 463 REST OF ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 464 REST OF ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 465 REST OF ASIA PACIFIC: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 466 REST OF ASIA PACIFIC: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 467 REST OF ASIA PACIFIC: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 468 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 469 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 470 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 471 LATIN AMERICA: VOLUME ANALYSIS OF COMPANION ANIMAL DIAGNOSTIC PRODUCTS, 2024-2031 (THOUSAND UNITS)
- TABLE 472 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 473 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 474 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 475 LATIN AMERICA: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 476 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 477 LATIN AMERICA: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 478 LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 479 LATIN AMERICA: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 480 LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 481 LATIN AMERICA: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 482 LATIN AMERICA: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 483 LATIN AMERICA: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 484 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 485 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 486 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 487 BRAZIL: KEY MACROINDICATORS
- TABLE 488 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 489 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 490 BRAZIL: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 491 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 492 BRAZIL: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 493 BRAZIL: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 494 BRAZIL: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 495 BRAZIL: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 496 BRAZIL: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 497 BRAZIL: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 498 BRAZIL: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 499 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 500 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 501 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 502 MEXICO: KEY MACROINDICATORS
- TABLE 503 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 504 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 505 MEXICO: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 506 MEXICO: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 507 MEXICO: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 508 MEXICO: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 509 MEXICO: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 510 MEXICO: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 511 MEXICO: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 512 MEXICO: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 513 MEXICO: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 514 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 515 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 516 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 517 ARGENTINA: KEY MACROINDICATORS
- TABLE 518 ARGENTINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 519 ARGENTINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 520 ARGENTINA: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 521 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 522 ARGENTINA: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 523 ARGENTINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 524 ARGENTINA: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 525 ARGENTINA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 526 ARGENTINA: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 527 ARGENTINA: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 528 ARGENTINA: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 529 ARGENTINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 530 ARGENTINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 531 ARGENTINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 532 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 533 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 534 REST OF LATIN AMERICA: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 535 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 536 REST OF LATIN AMERICA: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 537 REST OF LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 538 REST OF LATIN AMERICA: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 539 REST OF LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 540 REST OF LATIN AMERICA: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 541 REST OF LATIN AMERICA: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 542 REST OF LATIN AMERICA: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 543 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 544 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 545 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 546 MIDDLE EAST & AFRICA: VOLUME ANALYSIS OF COMPANION ANIMAL DIAGNOSTIC PRODUCTS, 2024-2031 (THOUSAND UNITS)
- TABLE 547 MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 548 MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 549 MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 550 MIDDLE EAST & AFRICA: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 551 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 552 MIDDLE EAST & AFRICA: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 553 MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 554 MIDDLE EAST & AFRICA: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 555 MIDDLE EAST & AFRICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 556 MIDDLE EAST & AFRICA: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 557 MIDDLE EAST & AFRICA: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 558 MIDDLE EAST & AFRICA: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 559 MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 560 MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 561 MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 562 GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 563 GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 564 GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 565 GCC COUNTRIES: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 566 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 567 GCC COUNTRIES: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 568 GCC COUNTRIES: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 569 GCC COUNTRIES: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 570 GCC COUNTRIES: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 571 GCC COUNTRIES: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 572 GCC COUNTRIES: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 573 GCC COUNTRIES: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 574 GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 575 GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 576 GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 577 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS
- TABLE 578 KINGDOM OF SAUDI ARABIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 579 KINGDOM OF SAUDI ARABIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 580 KINGDOM OF SAUDI ARABIA: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 581 KINGDOM OF SAUDI ARABIA: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 582 KINGDOM OF SAUDI ARABIA: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 583 KINGDOM OF SAUDI ARABIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 584 KINGDOM OF SAUDI ARABIA: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 585 KINGDOM OF SAUDI ARABIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 586 KINGDOM OF SAUDI ARABIA: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 587 KINGDOM OF SAUDI ARABIA: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 588 KINGDOM OF SAUDI ARABIA: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 589 KINGDOM OF SAUDI ARABIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 590 KINGDOM OF SAUDI ARABIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 591 KINGDOM OF SAUDI ARABIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 592 UNITED ARAB EMIRATES: KEY MACROINDICATORS
- TABLE 593 UAE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 594 UAE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 595 UAE: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 596 UAE: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 597 UAE: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 598 UAE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 599 UAE: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 600 UAE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 601 UAE: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 602 UAE: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 603 UAE: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 604 UAE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 605 UAE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 606 UAE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 607 REST OF GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 608 REST OF GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 609 REST OF GCC COUNTRIES: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 610 REST OF GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 611 REST OF GCC COUNTRIES: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 612 REST OF GCC COUNTRIES: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 613 REST OF GCC COUNTRIES: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 614 REST OF GCC COUNTRIES: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 615 REST OF GCC COUNTRIES: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 616 REST OF GCC COUNTRIES: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 617 REST OF GCC COUNTRIES: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 618 REST OF GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 619 REST OF GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 620 REST OF GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 621 REST OF MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 622 REST OF MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
- TABLE 623 REST OF MIDDLE EAST & AFRICA: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 624 REST OF MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 625 REST OF MIDDLE EAST & AFRICA: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 626 REST OF MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 627 REST OF MIDDLE EAST & AFRICA: GLUCOSE MONITORING MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 628 REST OF MIDDLE EAST & AFRICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 629 REST OF MIDDLE EAST & AFRICA: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 630 REST OF MIDDLE EAST & AFRICA: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 631 REST OF MIDDLE EAST & AFRICA: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 632 REST OF MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024-2031 (USD MILLION)
- TABLE 633 REST OF MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 634 REST OF MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 635 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN COMPANION ANIMAL DIAGNOSTICS MARKET
- TABLE 636 COMPANION ANIMAL DIAGNOSTICS MARKET: DEGREE OF COMPETITION
- TABLE 637 US COMPANION ANIMAL DIAGNOSTICS MARKET: DEGREE OF COMPETITION
- TABLE 638 EUROPE COMPANION ANIMAL DIAGNOSTICS MARKET: DEGREE OF COMPETITION
- TABLE 639 COMPANION ANIMAL DIAGNOSTICS MARKET: REGION FOOTPRINT
- TABLE 640 COMPANION ANIMAL DIAGNOSTICS MARKET: PRODUCT FOOTPRINT
- TABLE 641 COMPANION ANIMAL DIAGNOSTICS MARKET: TECHNOLOGY FOOTPRINT
- TABLE 642 COMPANION ANIMAL DIAGNOSTICS MARKET: ANIMAL TYPE FOOTPRINT
- TABLE 643 COMPANION ANIMAL DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
- TABLE 644 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS
- TABLE 645 COMPANION ANIMAL DIAGNOSTICS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-MAY 2026
- TABLE 646 COMPANION ANIMAL DIAGNOSTICS MARKET: DEALS, JANUARY 2022- APRIL 2026
- TABLE 647 COMPANION ANIMAL DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2022- APRIL 2026
- TABLE 648 COMPANION ANIMAL DIAGNOSTICS MARKET: OTHER DEVELOPMENTS, JANUARY 2022- APRIL 2026
- TABLE 649 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW
- TABLE 650 IDEXX LABORATORIES, INC.: PRODUCTS OFFERED
- TABLE 651 IDEXX LABORATORIES, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-MAY 2026
- TABLE 652 ANTECH DIAGNOSTICS, INC.: COMPANY OVERVIEW
- TABLE 653 ANTECH DIAGNOSTICS, INC.: PRODUCTS OFFERED
- TABLE 654 ANTECH DIAGNOSTICS, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
- TABLE 655 ANTECH DIAGNOSTICS, INC.: EXPANSIONS, JANUARY 2022-MAY 2026
- TABLE 656 ZOETIS SERVICES LLC: COMPANY OVERVIEW
- TABLE 657 ZOETIS SERVICES LLC: PRODUCTS OFFERED
- TABLE 658 ZOETIS SERVICES LLC: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-MAY 2026
- TABLE 659 ZOETIS SERVICES LLC: DEALS, JANUARY 2022-MAY 2026
- TABLE 660 ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2022-MAY 2026
- TABLE 661 ZOETIS SERVICES LLC: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2026
- TABLE 662 FUJIFILM CORPORATION: COMPANY OVERVIEW
- TABLE 663 FUJIFILM CORPORATION: PRODUCTS OFFERED
- TABLE 664 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
- TABLE 665 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
- TABLE 666 BIOMERIEUX: COMPANY OVERVIEW
- TABLE 667 BIOMERIEUX: PRODUCTS OFFERED
- TABLE 668 BIOMERIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-MAY 2026
- TABLE 669 BIONOTE: COMPANY OVERVIEW
- TABLE 670 BIONOTE: PRODUCTS OFFERED
- TABLE 671 BIONOTE: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-MAY 2026
- TABLE 672 BIONOTE: DEALS, JANUARY 2022-MAY 2026
- TABLE 673 VIRBAC: COMPANY OVERVIEW
- TABLE 674 VIRBAC: PRODUCTS OFFERED
- TABLE 675 VIRBAC: DEALS, JANUARY 2022-MAY 2026
- TABLE 676 VIRBAC: EXPANSIONS, JANUARY 2022-MAY 2026
- TABLE 677 RANDOX LABORATORIES LTD.: COMPANY OVERVIEW
- TABLE 678 RANDOX LABORATORIES LTD.: PRODUCTS OFFERED
- TABLE 679 RANDOX LABORATORIES LTD.: DEALS, JANUARY 2022-MAY 2026
- TABLE 680 RANDOX LABORATORIES LTD.: EXPANSIONS, JANUARY 2022-MAY 2026
- TABLE 681 INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW
- TABLE 682 INDICAL BIOSCIENCE GMBH: PRODUCTS OFFERED
- TABLE 683 INDICAL BIOSCIENCE GMBH: PRODUCT ENHANCEMENTS, JANUARY 2022-MAY 2026
- TABLE 684 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
- TABLE 685 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
- TABLE 686 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: PRODUCT LAUNCHES, JANUARY 2022-MAY 2026
- TABLE 687 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: EXPANSIONS, JANUARY 2022-MAY 2026
- TABLE 688 BOULE: COMPANY OVERVIEW
- TABLE 689 BOULE: PRODUCTS OFFERED
- TABLE 690 BOULE: PRODUCT LAUNCHES, JANUARY 2022-MAY 2026
- TABLE 691 BOULE: DEALS, JANUARY 2022-MAY 2026
- TABLE 692 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW
- TABLE 693 INNOVATIVE DIAGNOSTICS: PRODUCTS OFFERED
- TABLE 694 INNOVATIVE DIAGNOSTICS: OTHER DEVELOPMENTS, JANUARY 2022-MAY 2026
- TABLE 695 MEGACOR DIAGNOSTIK GMBH: COMPANY OVERVIEW
- TABLE 696 MEGACOR DIAGNOSTIK GMBH: PRODUCTS OFFERED
- TABLE 697 MEGACOR DIAGNOSTIK GMBH: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-MAY 2026
- TABLE 698 BIOGAL: COMPANY OVERVIEW
- TABLE 699 BIOGAL: PRODUCTS OFFERED
- TABLE 700 GOLD STANDARD DIAGNOSTICS: COMPANY OVERVIEW
- TABLE 701 AGROLABO S.P.A.: COMPANY OVERVIEW
- TABLE 702 PRECISION BIOSENSOR, INC.: COMPANY OVERVIEW
- TABLE 703 SKYLA CORPORATION: COMPANY OVERVIEW
- TABLE 704 FASSISI, GMBH: COMPANY OVERVIEW
- TABLE 705 WOODLEY EQUIPMENT COMPANY LTD: COMPANY OVERVIEW
- TABLE 706 BIOPANDA REAGENTS LTD.: COMPANY OVERVIEW
- TABLE 707 SKYER, INC.: COMPANY OVERVIEW
- TABLE 708 RING BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
- TABLE 709 SHENZHEN BIOEASY BIOTECHNOLOGY, INC.: COMPANY OVERVIEW
- TABLE 710 RISK ASSESSMENT ANALYSIS
List of Figures
- FIGURE 1 COMPANION ANIMAL DIAGNOSTICS MARKET SEGMENTATION & REGIONAL SCOPE
- FIGURE 2 MARKET SCENARIO
- FIGURE 3 GLOBAL COMPANION ANIMAL DIAGNOSTICS MARKET, 2024-2031
- FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN COMPANION ANIMAL DIAGNOSTICS MARKET, 2022-2025
- FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF COMPANION ANIMAL DIAGNOSTICS MARKET
- FIGURE 6 HIGH-GROWTH SEGMENTS IN COMPANION ANIMAL DIAGNOSTICS MARKET, 2026-2031
- FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN COMPANION ANIMAL DIAGNOSTICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
- FIGURE 8 RISING COMPANION ANIMAL POPULATION TO FUEL MARKET GROWTH
- FIGURE 9 CONSUMABLES SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
- FIGURE 10 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING THE FORECAST PERIOD
- FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
- FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
- FIGURE 13 COMPANION ANIMAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 14 US: PET EXPENDITURE, DOGS VS CATS, 2024 (USD)
- FIGURE 15 COMPANION ANIMAL DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 16 COMPANION ANIMAL DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
- FIGURE 17 COMPANION ANIMAL DIAGNOSTICS MARKET: ECOSYSTEM ANALYSIS
- FIGURE 18 AVERAGE SELLING PRICE OF COMPANION ANIMAL DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2025 (USD)
- FIGURE 19 AVERAGE SELLING PRICE OF COMPANION ANIMAL DIAGNOSTIC PRODUCTS, BY REGION, 2025
- FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- FIGURE 21 COMPANION ANIMAL DIAGNOSTICS MARKET: INVESTMENT & FUNDING SCENARIO (2021-2025)
- FIGURE 22 COMPANION ANIMAL DIAGNOSTIC MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2015-MAY 2026)
- FIGURE 23 TOP APPLICANT COUNTRIES/REGIONS FOR COMPANION ANIMAL DIAGNOSTIC KITS PATENTS (JANUARY 2015-MAY 2026)
- FIGURE 24 AI USE CASES
- FIGURE 25 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR COMPANION ANIMAL DIAGNOSTIC PRODUCTS
- FIGURE 26 KEY BUYING CRITERIA FOR TOP THREE END USERS
- FIGURE 27 COMPANION ANIMAL DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT
- FIGURE 28 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT
- FIGURE 29 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT
- FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS IN THE COMPANION ANIMAL DIAGNOSTICS MARKET (2021-2025)
- FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS IN COMPANION ANIMAL DIAGNOSTICS (2025)
- FIGURE 32 RANKING OF KEY PLAYERS IN COMPANION ANIMAL DIAGNOSTICS MARKET, 2025
- FIGURE 33 US: MARKET SHARE ANALYSIS OF KEY PLAYERS (2025)
- FIGURE 34 EUROPE: MARKET SHARE ANALYSIS OF KEY PLAYERS (2025)
- FIGURE 35 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
- FIGURE 36 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPANY FOOTPRINT
- FIGURE 37 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
- FIGURE 38 COMPANION ANIMAL DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
- FIGURE 39 R&D EXPENDITURE OF KEY PLAYERS IN COMPANION ANIMAL DIAGNOSTICS MARKET, 2022-2025
- FIGURE 40 EV/EBITDA OF KEY VENDORS
- FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 42 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 43 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2025)
- FIGURE 44 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
- FIGURE 46 BIOMERIEUX: COMPANY SNAPSHOT (2025)
- FIGURE 47 VIRBAC: COMPANY SNAPSHOT (2025)
- FIGURE 48 BOULE: COMPANY SNAPSHOT (2025)
- FIGURE 49 COMPANION ANIMAL DIAGNOSTICS MARKET: RESEARCH DESIGN
- FIGURE 50 PRIMARY SOURCES
- FIGURE 51 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
- FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE)
- FIGURE 53 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
- FIGURE 54 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
- FIGURE 55 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
- FIGURE 56 REVENUE ANALYSIS OF TOP FIVE COMPANIES: COMPANION ANIMAL DIAGNOSTICS MARKET (2025)
- FIGURE 57 DEMAND-SIDE MARKET ESTIMATION FOR COMPANION ANIMAL DIAGNOSTICS MARKET
- FIGURE 58 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF COMPANION ANIMAL DIAGNOSTICS MARKET (2026-2031)
- FIGURE 59 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
- FIGURE 60 TOP-DOWN APPROACH
- FIGURE 61 BOTTOM-UP APPROACH
- FIGURE 62 MARKET DATA TRIANGULATION METHODOLOGY
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.